Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world polidocanol injection study for hemorrhoid disease
ChiCTR2300073657Phase 4Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 10XB101 in hemorrhoid and internal hemorrhoid, sponsored by Sun Yat-sen University. Primary endpoint: Anal scope examination results. Started Jul 2023; status: recruiting.
02
Drugs
10XB101
03
Conditions
hemorrhoidinternal hemorrhoid
Beyond the preview
Go deeper on ChiCTR2300073657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073657.